US Patent Issued to FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON-INSTITUT DE RECERCA on July 14 for "Method for selecting a patient for a reperfusion therapy" (Spanish Inventor)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,681,022, issued on July 14, was assigned to FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON-INSTITUT DE RECERCA (Barcelona, Spain).

"Method for selecting a patient for a reperfusion therapy" was invented by Joan Montaner Villalonga (Barcelona, Spain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to a method for selecting a patient suffering stroke for a reperfusion therapy based on determining the level of retinol binding protein-4 (RBP4) and N-terminal fragment of B-type natriuretic peptide (NT-proBNP) in an isolated sample of said patient. The invention also relates to a method of differentiating ischemic stroke from haemorrhagic st...